Literature DB >> 8611791

Department of Health is fair to patients with osteoporosis.

D Barlow1, C Cooper, J Reeve, D Reid.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8611791      PMCID： PMC2349897          DOI： 10.1136/bmj.312.7026.297

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Bone densitometry in clinical practice.

Authors:  J E Compston; C Cooper; J A Kanis
Journal:  BMJ       Date:  1995-06-10

2.  Risk factors for hip fracture.

Authors:  C Cooper; D J Barker
Journal:  N Engl J Med       Date:  1995-03-23       Impact factor: 91.245

3.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

4.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; M C Nevitt; W S Browner; K Stone; K M Fox; K E Ensrud; J Cauley; D Black; T M Vogt
Journal:  N Engl J Med       Date:  1995-03-23       Impact factor: 91.245
  4 in total
  1 in total

1.  What do Norwegian women and men know about osteoporosis?

Authors:  J H Magnus; R M Joakimsen; G K Berntsen; A Tollan; A J Søogaard
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.